Member Info for Candid

I think it’s likely AP101 interim readout will be announcd either tomorrow or on Monday.
If not then definitely by middle of next week - to allow warrant holders to exercise by the 11th Jan deadline.
GLA

This is finally getting some attention, major catalysts are now within the next couple of weeks.
Personally I can’t see anything but positive announcements for both AP101 and AP103.

AMYT shares are fairly illiquid and can move up fast.
Can we see a price over 24p in Jan? Don’t see why not.
If all warrants exercised at 24p, it can bring in a tidy £5m into the coffers too.

IAG will not get drawn into this rescue bid for Flybe unless Virgin make a move. This will simply be a reaction to protect IAG‘s market share, particularly on the Manchester traffic.
IAG have bigger fish to fry and are more concerned about the threat from Norwegian Air who are really cutting into BA’s Trans Atlantic business and IAG have already had two takeover bids rejected by Norwegian.

Virgin know that if they make a bid for Flybe then IAG will be forced into play, so my view is that a bidding war between the two is probably unlikely.
As for Flybe’s slots at LHR, they were originally released by BA after thier takeover of BMI. These slots are ‘restricted’ and not as lucrative as some posters on here are suggesting.

This could be huge. If proved successful for EB, it can disrupt the viral gene therapy market.

https://dbei.gov.ie/en/What-We-Do/Innovation-Research-Development/Disruptive-Technologies-Innovation-Fund/DTIF-Awards-Under-First-Call-2018.html

Interim Data
Amryt expects the final patient required for the unblinded interim efficacy analysis to be enrolled by the end of September. Accordingly, the unblinded interim efficacy analysis is on track and expected to be completed in late Q4 2018

Top Line Data
Assuming a positive unblinded interim efficacy analysis and no additional patients are added to the study, the Group expects read out of top-line data from the EASE Phase III study in Q2 2019.

The price of HZM in Canada on TSX is much higher than the LSE price.
Director purchased at 5c which is 3p equivalent. In fact all buys on TSX in recent days appear to be at 5c. (3p)

Strange that the TSX buy price is around 50% higher than the LSE buy price.

Just noticed that the clinical centres have been updated on Friday, new centres have been added including a first US site in Texas.
I would have that thought this is an encouraging update and early indication that the trial will be continuing into next stage following the interims.

https://www.clinicaltrials.gov/ct2/show/study/NCT03068780?term=epidermolysis+bullosa+amryt&recrs=abdf&rank=1&show_locs=Y#locn

I remember Richard Grifitts from another share Aureus mining (now Avesoro). He also sold down heavily on the lead up to finacing, most likely expecting the equity raise that followed and then loaded up again at a lower price.
Always makes me wonder if significant investors get a wind of an equity raise before anyone else...
Could just be a calculated guess on his part.
Still, depends on what financing option is selected, there is also a chance that there won’t be any significant equity raised at all.

Everyone on here keeps mentioning Lombard, what about RG who is a private investor, Jeremy did mention specifically that it was a private investor likely selling after the FS was published.
Richard Griffiths HZM holding was 14.5% in Dec 2017 and now it is 6.7% (Sep 18)

According to available data JM (and other directors) do own a significant amount of shares, so please stop misleading other investors on here.

or perhaps they now have two geologists

So the former company geologist was not up to the job and has been fired?

Have to agree, well oversold in recent weeks, looks like some excitement may be building on the mentioned acquisition for more blue sky potential.
Director transfer to ISA does seem positive, nobody adds shares into their valuable ISA allowance if there’s a risk of if getting trashed

After the recent retrace, the stage is set for the next leg up.

U308 Spot price still moving up steadily, now at $27.20 per pound.

Anybody have any analyst estimates for tungsten prices?
(Short, medium and long term based on demand/supply fundamentals)
Thanks

I dont think there is much mystery with Glenover, it’s well reported that the Limpopo province has a backlog with mining licence applications and it is obviously delayed.
We won’t get the deal with the MPP signed until the mining rights are granted.

Related topic, was good to see UK’s visit to SA yesterday promising £billions of investment, a lot of this will go to Agri business

“Sharktooth Zone diamond core drill programme and drilling on the first borehole M2-041 commenced 17 April. The programme plans for these holes to reach depths of between 775 and 900 metres.”

If diorite was the expected target, why on earth (no pun intended) did they stop drilling before they reached the diorite target??
I’m no geologist, but I don’t buy this explanation about difficulty in drilling, they knew exactly what they were up against before drillling in this area and were prepared to drill upto 900m, so why stop at 500m when the diorite was not too far to go?
The 2nd hole supposedly has a shallower diorite target, but if they can’t correctly predict where the diorite starts in the first hole what makes them sure where the diorite starts in the 2nd hole?
Also if this is the case why not start your drilling programme on the shallower targets first?

Automatic buys continue to flood in.

Lee, the uranium explorers and developers have not really responded to the increase in spot price yet, I think this is probably due to the general summer correction in metals/commodities and also the GlobalX Funds Uranium ETF index adjustment where they had to reduce all their uranium holdings across the board. This adjustment is nearly over I understand, so hopefully patience will soon be rewarded.

I think the price has drifted mainly due to the major correction in metal prices this summer.
Price of nickel is down around 16% in the last couple of months and copper even more, mainly due to strength of dollar and tensions in China and EM about the impact of trade war.

I’m expecting a recovery in metals in Q4 but at the moment no news will provide a significant boost, unless the DFS unlocks the path for a quick takeover by one of the majors. Good time to top up anyway.

Decent write-up. Personally I think price target can be much higher too. http://www.thisismoney.co.uk/money/investing/article-6050811/MIDAS-SHARE-TIPS-Sitting-pile-uranium-good.html